A U.S. Food and Drug Administration advisory panel on Tuesday voted narrowly to recommend emergency use of Merck’s new antiviral pill to help prevent severe COVID-19 in high-risk patients. By a 13-10 count, the panelists recommended molnupiravir for use by older COVID-19 patients or those who have medical conditions that make them especially susceptible to… read on > read on >
The first wave of girls to receive the HPV vaccine are much less likely to contract or die from cervical cancer than women just a few years older, a new study reports. Nearly all cases of cervical cancer are caused by human papillomavirus (HPV), for which a vaccine has been available since 2006. Cervical cancer… read on > read on >
Coffee lovers know a steaming cup of java can quickly deliver energy and mental clarity every morning, but new research suggests it may also guard against Alzheimer’s disease in the long run. “Worldwide, a high proportion of adults drink coffee every day, making it one of the most popular beverages consumed,” said lead researcher Samantha… read on > read on >
Regeneron Pharmaceuticals said Tuesday that its antibody cocktail, which is used widely to treat COVID-19 patients, may be less effective against the Omicron variant. The company noted that prior analyses suggest that its monoclonal antibody cocktail, and similar drugs, could lose effectiveness against the variant. Further research is ongoing, according to Regeneron, which added there… read on > read on >
TUESDAY, Nov. 30. 2021 (HealthDy News) — Amid growing concerns about the new Omicron variant, New York Governor Kathy Hochul and New York City Health Commissioner Dr. Dave Chokshi have advised all residents to wear masks while indoors. “Today, I am issuing a Commissioner’s Advisory STRONGLY recommending that all New Yorkers wear a mask AT… read on > read on >
Pfizer Inc. is expected to seek approval this week for emergency use of its booster shots among American teens ages 16-17. Sources familiar with the matter told The New York Times that the U.S. Food and Drug Administration could give the green light in about a week, which would make the Pfizer booster shot the… read on > read on >
Besides its terrible impact on mental health, postpartum depression can also bring long-term financial struggles to affected women, new research shows. “These findings highlight the importance of screening and expanding access to mental health support services for low-income pregnant and postpartum women,” said study author Slawa Rokicki, an instructor at Rutgers School of Public Health… read on > read on >
A heart condition, myocarditis, has been found in a number of U.S. college athletes who have had COVID-19, a new study finds. Myocarditis has also been linked in some young people to the COVID vaccine. But the odds are far greater that this inflammation of the heart muscle will occur in those who get COVID… read on > read on >
Hopes for an easing of the pandemic were dealt a major setback over the Thanksgiving weekend, with news that a variant first spotted in southern Africa carries a multiplicity of mutations that might make it resistant to approved vaccines. At an emergency meeting convened Friday by the World Health Organization, the agency dubbed the variant,… read on > read on >
As concerns about the new Omicron variant grow, vaccine makers say they’re already working on ways to protect people against the potential new threat. Pfizer said it and its partner BioNTech could develop and produce a “tailor-made vaccine” in about 100 days if a “vaccine-escape” variant emerges, NBC News reported. Meanwhile, Moderna said it was… read on > read on >
